Laurel Organics Ltd (530313) Fair Value & Analysis
Other · IN · Market cap ₹1.4B
Fair value as of: Jul 4, 2026
From 24 valuation models · updated today
Share price −2.2% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹23.55 – ₹80.78 · fair‑value band ₹29.32 – ₹54.46 · the ₹32.27 price screens below the ₹40.98 fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Laurel Organics Ltd (530313) currently trades at ₹32.27, while our model-based Fair Value estimate is ₹40.98 — implying the stock looks roughly 27.0% undervalued today. We read business quality at 54/100 (solid quality), in the Other sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
The stock trades on a trailing P/E of 55.9. Fundamentals as of Jul 4, 2026
About the company
Laurel Organics Ltd manufactures and sells pharmaceutical-bulk drugs in India. The company offers Benfotiamine, Cilnidipine, Gliclazide, Levosulpride, Rosuvastatin Calcium, Tranexamic Acid, Benidipine, Teneligliptin Hydrate Hydrobromide, Acotiamide, Citicoline Sodium, Luliconazole, Deflazacort, Voglibose, Oxaceprol, Ursodeoxycholic Acid, Bacitracin Zinc, Isotretinoin, and Tretinoin, as well as vitamin B1, calcium channel blocker, central stimulant/nootropic agent, and choleretic agent. It also provides products for various therapeutic categories, which comprise antidiabetic, antipsychotic, antihyperlipidemic, hemostatic, antihypertensive, antidiabetic, antiemetic, anti-fungal, anti-inflammatory, and anti-acne. The company was incorporated in 1993 and is based in New Delhi, India. Laurel Organics Ltd is a subsidiary of Kimia Biosciences Ltd.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Laurel Organics Ltd reported revenue of ₹1.2B in FY2025 versus ₹1.3B in FY2021, a compound −2.7%/yr. Reported net income was ₹96.1M in FY2025, compounding +17.1%/yr from FY2021.
Is 530313 fairly valued? → Check now
Similar stocks
6 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| There MOH | €521.90 | €269.92 | -48% |
| Sony Corporation SON1 | €17.58 | €39.38 | +124% |
| Federal Home Loan Mortgage Corporation FREJO | $16.84 | $64.93 | +286% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹279.60 | -81% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
Explore undervalued stocks
Frequently asked questions
Is Laurel Organics Ltd (530313) undervalued?
What is the fair value of 530313?
What is the quality score of 530313?
What is the net profit margin of 530313?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.